Ali Aria Razmaria, MD, MSc
Nuclear Medicine Physician
Nuclear Medicine; PET/CT; Novel PET Tracers; Radionuclide Therapies
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, Univeristy of Vienna
Nuclear Medicine - UCLA Medical Center
Oncologic Imaging - UCLA Medical Center
As a nuclear medicine physician, my specialization is in the medical use of radioisotopes linked to distinct elements and molecules to characterize and treat disease processes in the body, such as cancer. Molecular imaging and therapy is changing the way we think about the detection and treatment of diseases, which is especially beneficial for people with cancer.
My research work is centered around genitourinary diseases and cancers with an emphasis on the diagnosis, imaging, and treatment of prostate cancer in its various stages. Equipped with clinical experience from training in family medicine, urology, and nuclear medicine, my research aims to answer clinical questions that directly translate to improved patient care.
The importance of patient-centered care in cancer treatment is evident to me based on personal experience of losing a family member to an aggressive type of prostate cancer. Since then, the guiding principle for me in practicing medicine has been to put myself in the shoes of patients to fully understand their situation and tailor recommendations accordingly.
Awards and Honors
- Roentgen Fellow Research Award, Radiological Society of North America
- Robert Henkin Award, Society of Nuclear Medicine and Molecular Imaging
- Clinical Trials Co-Investigated by Dr. Razmaria
- A Phase I Study of CC-90011 Alone and with Abiraterone/Prednisone in Men with Metastatic Castration-Resistant Prostate Cancer
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Visit PubMed for a full listing of Dr. Razmaria’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Ali Aria Razmaria discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.